<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19630" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Clostridial Cholecystitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kowalski</surname>
            <given-names>Andrew</given-names>
          </name>
          <aff>Mclaren Macomb</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kashyap</surname>
            <given-names>Sarang</given-names>
          </name>
          <aff>Beckley Appalachian Regional Healthcare Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mathew</surname>
            <given-names>George</given-names>
          </name>
          <aff>University of Pelita Harapan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pfeifer</surname>
            <given-names>Christopher</given-names>
          </name>
          <aff>Henry Ford Allegiance Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Kowalski declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarang Kashyap declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>George Mathew declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Pfeifer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19630.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Emphysematous cholecystitis is a fulminant variety of acute cholecystitis that differs in its pathology and epidemiology from cholecystitis induced by gallstones. The characteristic feature of this sinister variant of cholecystitis is the presence of gas in the lumen and wall of the gallbladder. The presence of gas may be detected elsewhere in the biliary tract or adjacent structures in addition to gas in the gallbladder wall. Emphysematous cholecystitis occurs in about 1% of all cases of acute cholecystitis but carries significantly higher morbidity and mortality. Individuals most susceptible to emphysematous cholecystitis are people with diabetes mellitus and those with a weak immune system. This activity reviews the evaluation of patients with an emphysematous gallbladder and the role of the interprofessional team in managing this life-threatening condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of emphysematous cholecystitis.</p></list-item><list-item><p>Review the frequency of emphysematous cholecystitis.</p></list-item><list-item><p>Outline patients that are at highest risk of developing emphysematous cholecystitis.</p></list-item><list-item><p>Summarize the interprofessional teams coordination of care in a patient with emphysematous cholecystitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19630&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19630">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19630.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Emphysematous cholecystitis is a fulminant&#x000a0;variety of acute cholecystitis that differs in its pathology and epidemiology from cholecystitis induced by gallstones. The characteristic feature of this sinister variant&#x000a0;of cholecystitis is the presence of gas in the lumen and wall of the gallbladder. The presence of gas may be detected elsewhere in the biliary tract or adjacent&#x000a0;structures in addition to gas in the gallbladder wall. Emphysematous cholecystitis occurs in about 1% of all cases of acute cholecystitis but carries significantly higher morbidity and mortality. Individuals most susceptible to emphysematous cholecystitis are people with&#x000a0;diabetes mellitus and those with a weak immune system.<xref ref-type="bibr" rid="article-19630.r1">[1]</xref><xref ref-type="bibr" rid="article-19630.r2">[2]</xref><xref ref-type="bibr" rid="article-19630.r3">[3]</xref><xref ref-type="bibr" rid="article-19630.r4">[4]</xref></p>
      </sec>
      <sec id="article-19630.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The first reported case of emphysematous cholecystitis was by Stoltz in 1901. About 1% to 3% of patients with acute cholecystitis can develop this variant. This fulminant form of cholecystitis has been&#x000a0;reported to be more common in older patients who also have diabetes mellitus. The prevalence of emphysematous&#x000a0;cholecystitis is three times higher in men compared to women. There is also an association between peripheral vascular disease and immunosuppression. The mortality due to this life-threatening form of cholecystitis is reported to be around 15% to 25%.<xref ref-type="bibr" rid="article-19630.r5">[5]</xref><xref ref-type="bibr" rid="article-19630.r6">[6]</xref><xref ref-type="bibr" rid="article-19630.r7">[7]</xref><xref ref-type="bibr" rid="article-19630.r8">[8]</xref>&#x000a0;Diabetes is noted to be present in 30% to 75% of patients with this disorder. The mean age of diagnosis is around 60.</p>
        <p>Micro-organisms that have been isolated in patients with emphysematous cholecystitis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Clostridia</p>
          </list-item>
          <list-item>
            <p>Klebsiella</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Escherichia coli</italic>
</p>
          </list-item>
          <list-item>
            <p>Enterococci</p>
          </list-item>
          <list-item>
            <p>Anaerobic streptococci</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19630.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Ischemia of the gallbladder is considered the key etiological factor in the development of this uncommon, life-threatening condition. This situation develops predominantly in an age group older than 50 years. There is an increased incidence, especially among male diabetics. In patients who develop emphysematous cholecystitis, gallstones are often detected; however,&#x000a0;the proportion of acalculous&#x000a0;cholecystitis is three-fold compared to the acute cholecystitis group.</p>
      </sec>
      <sec id="article-19630.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Gallbladder ischemia as a result of vascular compromise of the cystic artery is the initiating factor in the development of this pathology. Poor perfusion results in ischemia&#x000a0;and necrosis of the gallbladder wall. The presence of ischemic tissue results&#x000a0;in a secondary infection, with gas-forming organisms, and leads to this condition. Gas produced by the gas-forming organisms is located in the lumen or wall of the gallbladder but can occasionally spread to other parts of the biliary tract as well as peritoneum and retroperitoneum. A background of diabetes in many of these patients creates a microenvironment that promotes the growth of anaerobic bacteria. A pathological examination of removed specimens of emphysematous cholecystitis shows a higher degree of endarteritis obliterans when compared to acute cholecystitis. The causative organisms are <italic toggle="yes">Escherichia coli,&#x000a0;Aerobactor aerogens, Klebsiella</italic>&#x000a0;spp, and<italic toggle="yes"> Salmonella</italic> spp Gangrene, perforation, and pericholecystic abscess may ensue. Emphysematous cholecystitis&#x000a0;is also reported in patients undergoing hemodialysis, with changes during the procedure causing a compromise&#x000a0;of visceral circulation including the cystic artery, and leading to ischemia and devitalization of the gallbladder. This form of cholecystitis has significant mortality, bacteria-produced&#x000a0;endotoxin, and a&#x000a0;higher incidence of gangrene and perforation of the gallbladder.</p>
      </sec>
      <sec id="article-19630.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The symptoms of patients with emphysematous cholecystitis often are suggestive of acute cholecystitis which can be indistinguishable from that&#x000a0;of any other acute upper abdominal pathology such as a liver abscess or a perforated duodenal ulcer. The usual combination of presenting symptoms is right upper quadrant pain and fever&#x000a0;with nausea&#x000a0;or vomiting. The lack of dramatic&#x000a0;symptoms often does not alert the clinician to an underlying sinister pathology. The symptoms&#x000a0;may be trivial in patients with associated diabetes and renal failure; however, the patient's&#x000a0;condition may rapidly deteriorate despite the moderate pain. If not treated early, the patient can progress to a clinical picture of frank&#x000a0;sepsis and shock. Signs of peritonitis are an indication of perforation. Whenever there&#x000a0;is a delay, the patient can present with tachycardia, hypotension, and cardiovascular collapse.</p>
      </sec>
      <sec id="article-19630.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ultrasonography, the most common radiological imaging used for gallstone disease diagnosis, has a high specificity for detecting&#x000a0;gas&#x000a0;in the gallbladder wall. This indicates emphysematous cholecystitis, but the sensitivity is low. During an ultrasonogram, the air&#x000a0;in the wall&#x000a0;or lumen of the gallbladder&#x000a0;can interfere with the clear visualization&#x000a0;of the gallbladder The best imaging modality&#x000a0;to confirm the presence of emphysematous cholecystitis&#x000a0;is a contrast-enhanced abdominal computed tomography scan. The plain x-ray may reveal air and/or air-fluid levels in the gallbladder.</p>
        <p>A computed tomography scan will confirm the presence of gas in the gallbladder wall or lumen and provide accurate information about the&#x000a0;presence of air or fluid in the pericholecystic tissue, free air in the peritoneum, or rarely, retroperitoneum. The presence of air in the peritoneum or retroperitoneum represents a more severe form of emphysematous&#x000a0;cholecystitis. A suggested classification according to radiological&#x000a0;findings as progressive stages starting with the detection of air limited&#x000a0;to the gallbladder lumen and progressing to findings of air in the gallbladder and the pericholecystic tissue as the most advanced stage. MRI can provide accurate information on the presence of intramural air and necrosis. Blood work will usually reveal a leucocytosis,&#x000a0;and liver function tests may be normal or abnormal. Serum glucose levels are usually elevated.</p>
      </sec>
      <sec id="article-19630.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The definitive management of this condition is an emergency cholecystectomy upon diagnosis. It is possible to perform the cholecystectomy laparoscopically if gangrene or perforation of the gallbladder is not suspected. Clinical suspicion or confirmation of perforation and peritonitis indicates an open cholecystectomy. Open surgery&#x000a0;also&#x000a0;is the preferred option if there is an associated pneumoperitoneum&#x000a0;to rule out the presence of bowel perforation. The surgeon should have a low threshold for conversion to open due to the high chances of distorted anatomy or very fragile tissues.&#x000a0;At surgery, a severely inflamed gallbladder is one with evidence of air&#x000a0;in the pericholecystic tissue or foamy collection&#x000a0;detected along the hepatoduodenal ligament or the right retroperitoneum. An intraoperative cholangiogram helps to avoid bile duct injury when the anatomy cannot be delineated clearly. In patients without&#x000a0;evidence of peritonitis who cannot tolerate anesthesia because of a poor clinical condition, a reasonable intervention is to perform percutaneous radiological drainage as a temporizing option. The cholecystostomy can&#x000a0;be followed by the removal of the gallbladder at a later date once the patient's condition improves.<xref ref-type="bibr" rid="article-19630.r9">[9]</xref><xref ref-type="bibr" rid="article-19630.r10">[10]</xref><xref ref-type="bibr" rid="article-19630.r11">[11]</xref></p>
      </sec>
      <sec id="article-19630.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute cholecystitis</p>
          </list-item>
          <list-item>
            <p>Acute cholangitis</p>
          </list-item>
          <list-item>
            <p>Acute pancreatitis</p>
          </list-item>
          <list-item>
            <p>Chronic cholecystitis</p>
          </list-item>
          <list-item>
            <p>Choledocholithiasis</p>
          </list-item>
          <list-item>
            <p>Choledochoduodenal fistula</p>
          </list-item>
          <list-item>
            <p>Empyema in gallbladder</p>
          </list-item>
          <list-item>
            <p>Gallbladder perforation</p>
          </list-item>
          <list-item>
            <p>Obstructive jaundice</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19630.s10" sec-type="Staging">
        <title>Staging</title>
        <p>The following are the staging procedures:</p>
        <p>Stage 1: Gas in the gallbladder lumen with signs of cholecystitis. Air is only seen in some parts of the gallbladder</p>
        <p>Stage 2: Gas in the entire gallbladder wall.</p>
        <p>Stage 3: Gas in the pericholecystic fluid, within the wall and adjacent tissues, indicating gangrene and perforation.</p>
      </sec>
      <sec id="article-19630.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients with emphysematous cholecystitis can develop the following complications:</p>
        <list list-type="bullet">
          <list-item>
            <p>Septic shock</p>
          </list-item>
          <list-item>
            <p>Cardiovascular collapse</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19630.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications from surgery include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bile duct injury</p>
          </list-item>
          <list-item>
            <p>Bile duct leak</p>
          </list-item>
          <list-item>
            <p>Wound infection</p>
          </list-item>
          <list-item>
            <p>Postoperative abscess</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19630.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Patients with emphysematous cholecystitis are critically ill and best managed in the intensive care unit. Aggressive hydration, broad-spectrum antibiotics,&#x000a0;and cardiovascular support are necessary.</p>
      </sec>
      <sec id="article-19630.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Once the diagnosis is made, the following should be consulted:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intensivist</p>
          </list-item>
          <list-item>
            <p>Endocrinologist</p>
          </list-item>
          <list-item>
            <p>Radiologist for percutaneous drainage</p>
          </list-item>
          <list-item>
            <p>General surgeon</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19630.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Early recognition of emphysematous cholecystitis is necessary to avoid the high mortality that this fulminant&#x000a0;condition carries. In a patient with diabetes mellitus and renal failure who presents with right upper quadrant abdominal pain and hypotension, emphysematous cholecystitis should be high on the diagnostic possibilities</p>
      </sec>
      <sec id="article-19630.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Emphysematous cholecystitis is a surgical emergency that carries a high morbidity and mortality. Thus, it is best managed by an interprofessional team that includes an endocrinologist, general surgeon, emergency department physician, intensive care unit nurses, and an intensivist. As soon as the diagnosis is made the general surgeon should be consulted as the patient needs an emergency cholecystectomy. In unstable patients, percutaneous drainage by the radiologist may be life-saving. The cholecystostomy can&#x000a0;be followed by the removal of the gallbladder at a later date once the patient's condition improves. The outcomes for most patients with emphysematous cholecystitis are guarded, even after successful surgery.<xref ref-type="bibr" rid="article-19630.r12">[12]</xref><xref ref-type="bibr" rid="article-19630.r13">[13]</xref></p>
      </sec>
      <sec id="article-19630.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19630&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19630">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/clostridial-cholecystitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19630">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19630/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19630">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19630.s18">
        <title>References</title>
        <ref id="article-19630.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenberg</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Cherry-Bukowiec</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous cholecystitis.</article-title>
            <source>Surg Infect (Larchmt)</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>483</fpage>
            <page-range>483-5</page-range>
            <pub-id pub-id-type="pmid">23859687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohtani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsukui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moriya</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tobita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sekka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Makuuchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tajima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mitomi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Acute emphysematous cholecystitis associated with pneumobilia: a case report.</article-title>
            <source>Tokai J Exp Clin Med</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-6</page-range>
            <pub-id pub-id-type="pmid">9239802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>T&#x000f6;gel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sommer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Emphysematous cholecystitis (author's transl)].</article-title>
            <source>MMW Munch Med Wochenschr</source>
            <year>1981</year>
            <month>Apr</month>
            <day>24</day>
            <volume>123</volume>
            <issue>17</issue>
            <fpage>691</fpage>
            <page-range>691-4</page-range>
            <pub-id pub-id-type="pmid">6262639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huber</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>K&#x000fc;bler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Acute emphysematous cholecystitis].</article-title>
            <source>Helv Chir Acta</source>
            <year>1979</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>477</fpage>
            <page-range>477-81</page-range>
            <pub-id pub-id-type="pmid">226505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mentzer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Horsley</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>A comparative appraisal of emphysematous cholecystitis.</article-title>
            <source>Am J Surg</source>
            <year>1975</year>
            <month>Jan</month>
            <volume>129</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-5</page-range>
            <pub-id pub-id-type="pmid">174453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vera</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pei</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Schuster</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Validation of a new American Association for the Surgery of Trauma (AAST) anatomic severity grading system for acute cholecystitis.</article-title>
            <source>J Trauma Acute Care Surg</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>650</fpage>
            <page-range>650-654</page-range>
            <pub-id pub-id-type="pmid">29271871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mora-Guzm&#x000e1;n</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-P&#x000e9;rez</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Perforated emphysematous cholecystitis and Streptococcus bovis.</article-title>
            <source>Rev Esp Enferm Dig</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>166</fpage>
            <page-range>166-167</page-range>
            <pub-id pub-id-type="pmid">30421958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mora-Guzm&#x000e1;n</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Viamontes Ugalde</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous cholecystitis and cholecystocolic fistula.</article-title>
            <source>Acta Chir Belg</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>205</fpage>
            <page-range>205-206</page-range>
            <pub-id pub-id-type="pmid">30371144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiappacasse</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Soffia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Villacr&#x000e9;s</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Computed tomography imaging of complications of acute cholecystitis.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-199</page-range>
            <pub-id pub-id-type="pmid">30050243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manatakis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tsoukalos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous cholecystitis in a young patient with no risk factors.</article-title>
            <source>Pan Afr Med J</source>
            <year>2017</year>
            <volume>28</volume>
            <fpage>269</fpage>
            <pub-id pub-id-type="pmid">29881511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bundy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Srinivasa</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Gemmete</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Chick</surname>
                <given-names>JFB</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous Cholecystostomy: Long-Term Outcomes in 324 Patients.</article-title>
            <source>Cardiovasc Intervent Radiol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>41</volume>
            <issue>6</issue>
            <fpage>928</fpage>
            <page-range>928-934</page-range>
            <pub-id pub-id-type="pmid">29380004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Risk assessment scales and predictors for simple versus severe cholecystitis in performing laparoscopic cholecystectomy.</article-title>
            <source>Asian J Surg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>367</fpage>
            <page-range>367-374</page-range>
            <pub-id pub-id-type="pmid">26922627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19630.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koole</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Lohman</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>van Unen</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Emphysematous cholecystitis due to Clostridium perfringens successfully treated by cholecystectomy.</article-title>
            <source>Acta Chir Belg</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>116</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-7</page-range>
            <pub-id pub-id-type="pmid">27385144</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
